MVX-ONCO-2

N/A

Report date: 2024/04/02 18:01:49

Base Information

Drug NameMVX-ONCO-2
Drug Alias NameMVX-ONCO-2
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsChordoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaxivax Sa
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursHead and Neck NeoplasmsChordoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A